Nutrition advice used to come in one-size-fits-all form; that model is quickly being replaced by data-driven, individualized dietary science. According to recent industry research, the global precision nutrition market was valued at USD 6.23 billion in 2023 and is projected to grow from USD 7.20 billion in 2024 to USD 20.96 billion by 2031, representing a compound annual growth rate of 16.49% across the forecast period. This is one of the fastest-growing corners of the broader health and wellness economy, fueled by advances in biotechnology, personalized healthcare, and rising consumer appetite for dietary guidance tailored to their individual biology.
What Precision Nutrition Involves
Precision nutrition is a personalized approach to diet that factors in an individual’s genetic makeup, microbiome composition, metabolism, lifestyle, and environmental context to generate tailored dietary recommendations. Rather than relying on generic guidelines, it uses data-driven insights — biomarkers, DNA analysis, real-time monitoring of how someone’s body responds to specific foods — to optimize health outcomes on a person-by-person basis. This shift toward individualized dietary science is being made possible by the convergence of several technologies that, until recently, weren’t affordable or accessible enough for mainstream consumer use.
Chronic Disease and Genomics Are Driving Adoption
The rising global burden of chronic disease is a major force behind this market’s growth. As obesity, diabetes, cardiovascular disease, and autoimmune disorders become more prevalent, both consumers and healthcare providers are turning to data-driven nutrition plans that address individual genetic and metabolic profiles rather than generic dietary advice. Rapid advances in genetic testing, microbiome analysis, and AI-driven interpretation of nutritional data are accelerating this shift, with AI algorithms now capable of analyzing millions of genetic data points to generate tailored recommendations at a scale that simply wasn’t feasible before.
Research institutions are pushing the science forward too. In January 2025, Eurecat announced progress in precision nutrition using single-cell genomics technology, work aimed at assessing the health impact of alternative protein diets and characterizing cultured meat cells — research with direct implications for both food sustainability and personalized nutrition science.
Cost and Privacy Concerns Are Slowing Broader Adoption
Despite the momentum, precision nutrition still faces real barriers to mainstream adoption. Whole-genome sequencing, microbiome analysis, and AI-driven data interpretation all require significant investment in laboratory infrastructure and skilled personnel, which keeps many of these services priced as a premium offering rather than an accessible mainstream healthcare solution. Ongoing advances in biotechnology and increased competition among genetic testing companies are gradually pushing costs down, but affordability remains an obstacle for now.
Data privacy is the other major concern. The risk of breaches, unauthorized access, or misuse of sensitive genetic information makes some consumers hesitant to share the kind of personal data these services require. Companies operating in this space are responding by investing in stronger cybersecurity measures, encryption protocols, and strict adherence to data protection regulations, recognizing that consumer trust is just as critical to adoption as scientific accuracy.
The Rise of Microbiome-Based Nutrition
One of the most notable trends reshaping the market is the growing focus on gut microbiome health. As research continues to reveal how central gut health is to overall wellbeing, companies are increasingly using microbiome sequencing and probiotic-based interventions to build individualized diet plans aimed at optimizing digestion, immunity, and metabolic function. This is converging with a broader push into functional foods and nutraceuticals designed to deliver targeted benefits — improved cognitive function, better heart health, more effective weight management — all tailored to a person’s specific biological profile.
Institutional partnerships are also expanding the platform’s reach into clinical care. In February 2024, Hologram Sciences partnered with the Mayo Clinic to build a precision nutrition platform addressing malnutrition in surgical recovery, integrating machine learning and predictive analytics with the Clinic’s established clinical protocols to deliver more personalized post-surgical nutrition support.
Segment Breakdown
By technology, genomics led the market in 2023, generating USD 1.99 billion in revenue as genetic testing continues to be the most established and widely adopted method for generating personalized dietary recommendations. By application, general health and wellness captured the largest share at 38.46% in 2023 and is projected to reach USD 8.08 billion by 2031, reflecting the strong consumer preference for preventive, customized nutrition over reactive disease treatment. By end user, the residential segment is projected to reach USD 8.97 billion by 2031, driven by rising demand for home-based nutrition solutions integrated with digital health platforms and wearable technology.
Regional Landscape
North America held the largest regional share in 2023, at 33.78% of the global market, equivalent to USD 2.10 billion. A well-established healthcare system, strong government funding, and the presence of major pharmaceutical and biotechnology companies all support this leadership position, alongside favorable regulatory frameworks and fast-track approval pathways for precision medicine therapies. The U.S. Department of Agriculture underscored this commitment in mid-2024, investing USD 4.5 million to establish three new Nutrition Hubs focused on improving food and nutrition security in underserved communities using precision nutrition research.
Asia Pacific is projected to be the fastest-growing region, with a CAGR of 17.50% through 2031 and a forecast value of USD 4.93 billion by that year. Rising biotechnology investment, expanding genomic sequencing adoption in countries like China, Japan, and India, and increasing rates of chronic disease are all fueling demand for tailored dietary interventions across the region, supported further by advances in next-generation sequencing that make genetic profiling faster and more cost-effective.
Regulatory Frameworks
In the United States, the FDA regulates the safety, efficacy, and labeling of dietary supplements, functional foods, and nutrigenomics-based products. In Europe, the European Food Safety Authority evaluates health claims for functional foods, while companies must also comply with GDPR to protect sensitive genetic and health data. China’s National Medical Products Administration and National Health Commission oversee personalized nutrition product approval and ethical AI/genomics integration respectively, while Japan’s Ministry of Health, Labour and Welfare regulates functional foods requiring scientific validation before health claims can be made.
Competitive Landscape
Key players in this space include Viome Life Sciences Inc., ZOE Limited, Prenetics Global Limited, SelfDecode, 23andMe Inc., AMILI Pte. Ltd., HealthifyMe Wellness Private Limited, Segterra Inc., Nutrigenomix, and Vitaminpacks Inc., among others. Strategic partnerships are shaping the competitive landscape: Samsung Nordic partnered with health tech company Revive in February 2025 to integrate AI-driven genetic insights into Samsung’s health ecosystem, drawing on analysis of 200 million genome data points, while Prenetics teamed up with David Beckham in late 2024 to launch IM8 Health, a wellness brand offering daily supplement products built around comprehensive nutrition science.
Outlook
With a projected CAGR approaching 16.5% through 2031, precision nutrition is transitioning from a niche, premium wellness offering into a more mainstream component of preventive healthcare. As genetic testing costs continue to fall and digital health platforms make personalized dietary insights more accessible, this market looks set to remain one of the standout growth stories in the broader personalized medicine space.
